This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Prospects for Immunologic Enhancement During Neonatal Sepsis

Mitchell S. Cairo, MD

Am J Dis Child. 1989;143(1):40-46.

Abstract
• Neonatal host defense simulates a clinical state of immunodeficiency that predisposes the preterm and term newborn to overwhelming bacterial sepsis. There are various immunologic components that are deficient in the newborn and new methods to enhance their function. Defects in both the quantitative and qualitative aspects of the neonatal phagocyte contribute substantially to the immaturity of neonates' immune systems. The neonate lacks an adequate number of granulocyte bone marrow progenitor cells, and has a decreased neutrophil storage pool and an increased tendency to peripheral neutropenia during neonatal sepsis. Additionally, the neonatal granulocyte demonstrates altered physiologic function compared with that found in the adult with respect to chemotaxis, phagocytosis, oxidative metabolism, and bacterial killing. Some recent clinical studies have suggested the benefit of using adult neutrophil transfusions as adjuvant treatment during neonatal bacterial sepsis, yet other studies have found the use of polymorphonuclear neutrophil leukocyte transfusions to be inconclusive. Reduced circulating immunoglobulins and impaired production of specific antibody have also led to recent trials in the use of prophylactic intravenous immunoglobulin in preterm infants predisposed to sepsis. Recently, hematopoietic colony-stimulating factors have been demonstrated to improve in vitro neonatal neutrophil physiologic activity. Future therapy of neonatal sepsis will depend on new nontoxic methods for enhancing neonatal host defense.

(AJDC 1989;143:40-46)

Author Affiliations
From the Division of Neonatalogy and Hematology/Oncology, Childrens Hospital of Orange County, University of California, Irvine.

Footnotes
Accepted for publication Sept 21, 1988.

Reprint requests to Division of Neonatology and Hematology/Oncology, Childrens Hospital of Orange County, 455 S Main, Orange CA 92668 (Dr Cairo).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Enhancement of Neonatal Innate Defense: Effects of Adding an N-Terminal Recombinant Fragment of Bactericidal/Permeability-Increasing Protein on Growth and Tumor Necrosis Factor-Inducing Activity of Gram-Negative Bacteria Tested in Neonatal Cord Blood Ex Vivo
Levy et al.
Infect. Immun. 2000;68:5120-5125.
ABSTRACT | FULL TEXT  

Impaired Innate Immunity in the Newborn: Newborn Neutrophils Are Deficient in Bactericidal/Permeability-Increasing Protein
Levy et al.
Pediatrics 1999;104:1327-1333.
ABSTRACT | FULL TEXT  

Developmental Regulation of RNA Transcript Destabilization by A + U-rich Elements is AUF1-dependent
Buzby et al.
J. Biol. Chem. 1999;274:33973-33978.
ABSTRACT | FULL TEXT  

P-Selectin Expression by Endothelial Cells Is Decreased in Neonatal Rats and Human Premature Infants
Lorant et al.
Blood 1999;94:600-609.
ABSTRACT | FULL TEXT